Your session is about to expire
← Back to Search
TASC Intervention for Asthma (TASC Trial)
TASC Trial Summary
This trial is testing a new intervention to help people with asthma better follow their treatment plan.
TASC Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTASC Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.TASC Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am between 12 and 18 years old.My asthma is diagnosed as severe or moderate persistent.You have been diagnosed with a pervasive developmental disorder.I do not have chronic diseases except for asthma or allergies.You have a serious mental illness like schizophrenia.You have trouble understanding things because of memory or thinking problems.I use daily asthma medication, including inhaled steroids and a long-acting bronchodilator.
- Group 1: TASC Intervention
- Group 2: Treatment as Usual
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is this clinical trial enrolling patients who are under the age of 60?
"In order to qualify for this trial, patients must be young adults aged 12 to 18. Out of the total number of clinical trials taking place, 117 are for people under the age of 18 and 202 are for elderly patients."
How many people are currently involved in this clinical trial?
"That is correct. The trial, which has been updated as recently as June 22nd 2021, is looking for 70 individuals to participate at 1 site."
What are some of the risks associated with TASC Intervention?
"While there is some data suggesting that TASC Intervention is safe, it only received a score of 2 because there is no evidence yet to support its efficacy."
Is this research opportunity still available to potential participants?
"From what is published on clinicaltrials.gov, it appears that this study requires more patients and is actively seeking them. The trial was first announced on November 19th, 2019 with the most recent update being from June 22nd, 2021."
Are there specific inclusion criteria for patients who want to participate in this trial?
"The aim of this study is to recruit 70 adolescents aged 12-18 that suffer from asthma. To be eligible, patients must meet the following requirements: A diagnosis of severe-persistent or moderate-persistent asthma according to NAEPP guidelines, A daily prescription of an inhaled controller medication or a combination of an inhaled corticosteroid and long-acting beta agonist as well as a beta agonist bronchodilator English fluency for patient, caregiver, and clinician."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger